 |
10.29.2004
More on Fantasyland
|
Marginal Revolution has a post by Alex Tabborok on pharmaceuticals, linking to a recent New Yorker piece by Malcolm Gladwell.
One key point of both: U.S. prices are actually lower than prices in other nations for drugs that are off-patent because competition from generics keeps the price down. Few who favor re-importation would be willing to give up this part of our system.
posted by James DeLong : 10/29/2004 03:30:25 PM
|

|
|
|
|
 |